FYERS
Home
/
Stocks
/
Profit Loss
/
Procter & Gamble Health Profit & Loss

Procter & Gamble Health Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012Jun 2012
₹364 Cr₹370 Cr₹374 Cr₹325 Cr₹339 Cr₹311 Cr₹310 Cr₹313 Cr₹284 Cr₹252 Cr₹310 Cr₹305 Cr₹301 Cr₹321 Cr₹310 Cr₹298 Cr₹296 Cr₹268 Cr₹278 Cr₹273 Cr₹285 Cr₹219 Cr₹240 Cr₹264 Cr₹201 Cr₹228 Cr₹237 Cr₹225 Cr₹234 Cr₹231 Cr₹204 Cr₹226 Cr₹220 Cr₹198 Cr₹179 Cr₹206 Cr₹174 Cr₹237 Cr₹260 Cr₹278 Cr₹277 Cr₹216 Cr₹237 Cr₹256 Cr₹247 Cr₹199 Cr₹214 Cr₹221 Cr₹239 Cr₹194 Cr₹202 Cr₹207 Cr₹206 Cr₹182 Cr₹168 Cr₹188 Cr₹185 Cr
₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹4 Cr₹3 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹5 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹3 Cr₹3 Cr₹2 Cr₹5 Cr₹3 Cr₹2 Cr₹3 Cr₹6 Cr₹7 Cr₹11 Cr₹10 Cr₹6 Cr₹7 Cr₹17 Cr₹18 Cr₹7 Cr₹6 Cr₹6 Cr₹5 Cr₹8 Cr₹5 Cr₹5 Cr₹7 Cr₹8 Cr₹4 Cr₹7 Cr₹5 Cr₹7 Cr₹6 Cr₹5 Cr₹5 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr
₹368 Cr₹374 Cr₹378 Cr₹330 Cr₹343 Cr₹314 Cr₹314 Cr₹317 Cr₹286 Cr₹255 Cr₹315 Cr₹311 Cr₹307 Cr₹326 Cr₹315 Cr₹301 Cr₹299 Cr₹270 Cr₹283 Cr₹276 Cr₹288 Cr₹222 Cr₹246 Cr₹271 Cr₹212 Cr₹238 Cr₹243 Cr₹232 Cr₹251 Cr₹249 Cr₹212 Cr₹232 Cr₹226 Cr₹204 Cr₹186 Cr₹210 Cr₹178 Cr₹244 Cr₹268 Cr₹282 Cr₹283 Cr₹221 Cr₹244 Cr₹262 Cr₹252 Cr₹204 Cr₹220 Cr₹226 Cr₹243 Cr₹199 Cr₹208 Cr₹213 Cr₹211 Cr₹188 Cr₹173 Cr₹193 Cr₹190 Cr
₹270 Cr₹241 Cr₹269 Cr₹211 Cr₹254 Cr₹235 Cr₹192 Cr₹205 Cr₹243 Cr₹192 Cr₹215 Cr₹223 Cr₹262 Cr₹247 Cr₹209 Cr₹214 Cr₹244 Cr₹205 Cr₹223 Cr₹202 Cr₹244 Cr₹196 Cr₹159 Cr₹193 Cr₹156 Cr₹174 Cr₹192 Cr₹179 Cr₹184 Cr₹185 Cr₹194 Cr₹172 Cr₹174 Cr₹182 Cr₹180 Cr₹174 Cr₹163 Cr₹221 Cr₹242 Cr₹238 Cr₹249 Cr₹210 Cr₹221 Cr₹242 Cr₹226 Cr₹190 Cr₹217 Cr₹200 Cr₹212 Cr₹193 Cr₹190 Cr₹188 Cr₹186 Cr₹167 Cr₹145 Cr₹154 Cr₹160 Cr
₹103 Cr₹140 Cr₹115 Cr₹125 Cr₹94 Cr₹84 Cr₹127 Cr₹117 Cr₹50 Cr₹70 Cr₹107 Cr₹95 Cr₹51 Cr₹85 Cr₹113 Cr₹94 Cr₹62 Cr₹71 Cr₹67 Cr₹81 Cr₹51 Cr₹34 Cr₹94 Cr₹85 Cr₹64 Cr₹69 Cr₹55 Cr₹57 Cr₹72 Cr₹68 Cr₹23 Cr₹64 Cr₹57 Cr₹29 Cr₹12 Cr₹42 Cr₹20 Cr₹29 Cr₹32 Cr₹51 Cr₹41 Cr₹17 Cr₹32 Cr₹25 Cr₹32 Cr₹18 Cr₹6 Cr₹29 Cr₹35 Cr₹9 Cr₹21 Cr₹27 Cr₹28 Cr₹23 Cr₹31 Cr₹41 Cr₹33 Cr
₹14 L₹21 L₹10 L₹12 L₹12 L₹13 L₹15 L₹15 L₹20 L₹15 L₹19 L₹18 L₹17 L₹21 L₹23 L₹16 L₹2 L₹14 L₹12 L₹14 L₹18 L₹20 L₹19 L₹24 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹1 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹129 Cr₹133 Cr₹109 Cr₹119 Cr₹89 Cr₹79 Cr₹122 Cr₹111 Cr₹23 Cr₹63 Cr₹100 Cr₹88 Cr₹44 Cr₹79 Cr₹105 Cr₹87 Cr₹55 Cr₹65 Cr₹60 Cr₹74 Cr₹44 Cr₹26 Cr₹86 Cr₹77 Cr₹56 Cr₹65 Cr₹51 Cr₹53 Cr₹67 Cr₹63 Cr₹18 Cr₹60 Cr₹52 Cr₹28 Cr₹24 Cr₹37 Cr₹15 Cr₹23 Cr₹26 Cr₹44 Cr₹34 Cr₹11 Cr₹23 Cr₹20 Cr₹26 Cr₹13 Cr₹2 Cr₹27 Cr₹32 Cr₹6 Cr₹18 Cr₹24 Cr₹26 Cr₹21 Cr₹29 Cr₹39 Cr₹31 Cr
₹96 Cr₹95 Cr₹78 Cr₹89 Cr₹66 Cr₹61 Cr₹91 Cr₹82 Cr₹17 Cr₹47 Cr₹72 Cr₹66 Cr₹30 Cr₹59 Cr₹77 Cr₹64 Cr₹41 Cr₹51 Cr₹45 Cr₹55 Cr₹34 Cr₹16 Cr₹68 Cr₹59 Cr₹49 Cr₹46 Cr₹38 Cr₹36 Cr₹44 Cr₹41 Cr₹715 Cr₹52 Cr₹48 Cr₹23 Cr₹27 Cr₹32 Cr₹20 Cr₹15 Cr₹19 Cr₹29 Cr₹23 Cr₹8 Cr₹15 Cr₹13 Cr₹17 Cr₹10 Cr₹1 Cr₹18 Cr₹21 Cr₹4 Cr₹9 Cr₹16 Cr₹17 Cr₹14 Cr₹20 Cr₹26 Cr₹20 Cr

Share Price Live Stats

Open (₹)5,295.50
Volume (₹)14,032.00
High (₹)5,384.00
Upper Circuit6,354.50
Low (₹)5,205.50
Lower Circuit4,236.50
Prev Close5,295.50
52W High (₹)6,975.00
Price5,237.50
52W Low (₹)4,707.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)8752.85 Cr
Div. Yield (%)3.89
PE Ratio24.53
Debt to Equity0.00
Price to Book15.33
Book Value312.92
EPS (TTM)215.00
Face Value10.00
ROE (%)62.18

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
PGHLNSE
LTP
1W Low
1W High
Market cap (₹)
1746.4-13.6 (-0.77%)
1725.50
1776.60
4,24,466Cr
9023-317 (-3.39%)
8937.50
9431.50
2,46,222Cr
4580-76.9 (-1.65%)
4551.80
4682
1,76,301Cr
1124.7+7.2 (0.64%)
1107.30
1150.90
1,12,818Cr
2036.9+0.3 (0.01%)
2007.80
2069.20
1,10,823Cr
1314.6+13.6 (1.05%)
1300.20
1333.30
1,07,447Cr
1216+19 (1.59%)
1196.90
1250.70
1,03,471Cr
2335-33.5 (-1.41%)
2317.50
2426.80
97,850Cr
1662.9-30.1 (-1.78%)
1654.10
1715
96,836Cr
1953.2-3.3 (-0.17%)
1925.70
1964.90
89,629Cr
5237.5+32.5 (0.62%)
5151
5384
8,753Cr
Empty box

No content available